Should I Buy AVT? AVT 2026 Analysis

Should You Buy Avnet Inc (AVT) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

66.620

1 Day change

3.62%

52 Week Range

66.890

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient buyer: AVT is extended/overbought into resistance (RSI_6 ~87; price ~63 above R1 62.48), which raises near-term pullback risk.
Upside looks limited versus Wall Street targets (current ~63 vs. highest raised PT 65), while two major firms remain Underweight/Underperform.
Positive cyclical-recovery narrative and bullish options positioning help sentiment, but weakening YoY profitability (net income/EPS down) reduces conviction to chase at this level.

Intellectia Proprietary Trading Signals

AI Stock Picker: No signal on given stock today.
SwingMax: No signal on given stock recently.

Technical Analysis

Trend: Bullish structure (SMA_5 > SMA_20 > SMA_200) signals an established uptrend.
Momentum: MACD histogram positive (1.395) but positively contracting → upside momentum is fading.
Overbought: RSI_6 at ~87.4 indicates overheated conditions (higher chance of consolidation/pullback than immediate smooth continuation).
Levels: Pivot 56.84 (key bull/bear line). Immediate resistance already exceeded at R1 62.48; next resistance R2 65.96 (close to analyst high PT).
Pattern-based expectation: Model suggests mild 1-day move potential (~~+0.98%), but stronger 1-week/1-month probabilities (~~+9.9% / ~+10.1%)—still less attractive when buying into overbought conditions.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Sentiment skew: Very low put/call ratios (OI PCR 0.35; Volume PCR 0.18) = bullish/options market leaning calls.
Activity: Today’s option volume (26) is elevated vs 30-day average (~68% higher), suggesting increased attention.
Volatility: IV 30d ~38.8 vs historical vol ~25.0 and IV percentile ~86.8 → options are priced rich; market is paying up for near-term exposure (often around catalysts/strong moves).

Technical Summary

Sell

Buy

Positive Catalysts

- Earnings-driven momentum: Fiscal 2026/Q2 revenue and non-GAAP EPS both beat expectations.
- Fundamental narrative: Management/external commentary points to an ongoing cyclical recovery; book-to-bill improving QoQ (per Wells Fargo note).
- Analyst actions (directionally positive): Multiple price target increases after Q2 beat (even if ratings stay cautious).
- Options positioning: Strong call-leaning flows/positioning supports bullish near-term sentiment.

Neutral/Negative Catalysts

- Technical overheating: RSI deep overbought and MACD momentum contracting—risk of a near-term fade is elevated.
- Profitability deterioration YoY: Net income and EPS down materially despite revenue growth; gross margin slightly lower.
- Wall Street stance still skeptical: Underperform/Underweight ratings remain, implying pros see valuation/upside as constrained or recovery not fully proven.
- Price vs targets: Trading near the top of the updated target range (limited perceived upside before hitting valuation/target ceilings).

Financial Performance

Latest quarter: Fiscal 2026/Q2.
Growth: Revenue $6.319B, +11.58% YoY (clear top-line improvement).
Profitability: Net income $61.7M, -29.25% YoY; EPS $0.75, -24.24% YoY (earnings power declined YoY).
Margins: Gross margin 10.49%, down 0.29 YoY (slight compression).
Takeaway: Sales recovery is real, but earnings/margins are not yet confirming a clean, durable upcycle—this weakens the case to buy aggressively at an overbought price.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent changes: All three listed firms raised price targets after Q2 beat, but kept cautious ratings.
BofA (2026-02-01): PT raised to $55 (from $50), Underperform—wants proof that demand trends are sustainable.
Truist (2026-01-29): PT raised to $65 (from $55), Hold—acknowledges cyclical stabilization/recovery.
Wells Fargo (2026-01-29): PT raised to $48 (from $43), Underweight—recovery signs noted but still cautious, watching Western demand.
Wall Street pros/cons view: Pros see improving demand/book-to-bill and cyclical stabilization; cons focus on needing confirmation of sustainability and (implicitly) limited upside at current prices.
Influential buying/selling: Hedge funds and insiders are neutral (no notable trends). Congress trading: no recent data available.

3 Analyst Rating

Wall Street analysts forecast AVT stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for AVT is 49.33 USD with a low forecast of 43 USD and a high forecast of 55 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

0 Buy

1 Hold

2 Sell

Moderate Sell

Current: 64.290

Low

Averages

49.33

High

Current: 64.290

Low

Averages

49.33

High

BofA

Underperform

maintain

$50 -> $55

AI Analysis

2026-02-01

Reason

BofA

Price Target

$50 -> $55

AI Analysis

2026-02-01

maintain

Underperform

Reason

BofA raised the firm's price target on Avnet to $55 from $50 and keeps an Underperform rating on the shares. The company is executing well and reported fiscal Q2 results above expectations, the analyst tells investors in a research note. The firm awaits more confirmation on the sustainability of Avnet's demand trends before adjusting its rating.

Truist

Hold

maintain

$55 -> $65

2026-01-29

Reason

Truist

Price Target

$55 -> $65

2026-01-29

maintain

Hold

Reason

Truist raised the firm's price target on Avnet to $65 from $55 and keeps a Hold rating on the shares after its Q2 earnings beat. The company is inching along its cyclical recovery, with better results and outlook, the analyst tells investors in a research note. Cyclical stabilization is also "increasingly clear", the firm added.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for AVT

Unlock Now

AVT Should I Buy

AVT Should I Buy

Should You Buy Avnet Inc (AVT) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch